Baird Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsDec 17 11:31 ET · Ratings

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsDec 17 08:31 ET · Ratings

We're Hopeful That Larimar Therapeutics (NASDAQ:LRMR) Will Use Its Cash Wisely

Simply Wall StDec 17 08:04 ET

A Quick Look at Today's Ratings for Larimar Therapeutics(LRMR.US), With a Forecast Between $14 to $36

Moomoo NewsDec 17 08:00 ET · Ratings

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaDec 16 16:05 ET

Analyst Recommends Buy on Larimar Therapeutics Amid Misinterpreted Data and Overreaction

TipRanksDec 16 15:35 ET